(Total Views: 327)
Posted On: 06/20/2019 4:21:11 PM
Post# of 148936
I wasn't sure when it was due, bla or drug approval, so I looked it up for reference; It is both.
Quote:
In connection with purchase, the Company has two remaining milestone payments, (i) $0.5 million upon filing a BLA with the FDA or non-U.S. equivalent regulatory body and (ii) $5.0 million, which will become due at the time of the first U.S. new drug application approval by the FDA or other non-U.S. approval for the sale of leronlimab (PRO 140).
(1)
(0)Scroll down for more posts ▼
